Product image of Mino-50 (Minocycline) supplied by GNH India

Mino-50

Active Ingredient:
Minocycline
Origin:
EU

Mino-50 (Minocycline)

Minocycline, the active ingredient in Mino-50, is a tetracycline antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as acne vulgaris, skin infections, respiratory tract infections, and urinary tract infections in adults and adolescents.
GNH India supplies Mino-50 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teofarma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minocycline is indicated for bacterial infections affecting the skin, respiratory system, urinary tract, and pilosebaceous units.

  • Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin.
  • Skin infections: treats cellulitis, abscesses and other bacterial dermatoses.
  • Respiratory tract infections: effective against community‑acquired pneumonia and sinusitis caused by susceptible organisms.
  • Urinary tract infections: eradicates susceptible uropathogens in uncomplicated cystitis.

How It Works

  • Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA to the mRNA‑ribosome complex. This action prevents elongation of the nascent peptide chain, leading to a bacteriostatic effect against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Minocycline may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea or vomiting: gastrointestinal upset occurring in many patients.
  • Dizziness or vertigo: transient balance disturbances.
  • Photosensitivity: increased skin sensitivity to sunlight.
  • Skin discoloration: hyperpigmentation of the skin or nails.
  • Oral mucosal irritation: soreness or ulceration of the mouth lining.

Serious or Rare Side Effects

  • Drug‑induced lupus erythematosus: autoimmune reaction with systemic symptoms.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin and mucosal detachment.
  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Severe hypersensitivity: anaphylaxis or serum sickness‑like reactions.

Precautions & Warnings

Before prescribing Minocycline, clinicians should consider several safety measures.

  • Assess renal function: adjust use if creatinine clearance is markedly reduced.
  • Monitor liver enzymes: periodic testing is advised for prolonged therapy.
  • Avoid use in patients with known hypersensitivity to tetracyclines: risk of severe allergic reactions.
  • Use caution in pregnancy and lactation: safety data are limited and potential fetal effects exist.
  • Advise patients to avoid prolonged sun exposure: photosensitivity may increase risk of sunburn.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Minocycline can alter the activity of several concomitant medicines.

Major Interactions (Avoid)

  • Warfarin: potentiates anticoagulant effect, increasing INR and bleeding risk.
  • Oral contraceptives: reduces hormonal efficacy, raising the chance of unintended pregnancy.
  • Retinoids (e.g., isotretinoin): may increase intracranial pressure when combined.

Moderate Interactions (Monitor Closely)

  • Penicillins: possible antagonism reducing antibacterial effectiveness.
  • Methoxyflurane: enhanced neurotoxic potential.
  • Iron or calcium supplements: chelation may lower minocycline absorption; separate dosing by at least 2 hours.

Frequently Asked Questions

Mino-50 contains minocycline, a tetracycline antibiotic that is prescribed to treat bacterial infections such as acne vulgaris, various skin infections, community‑acquired respiratory tract infections, and uncomplicated urinary tract infections. The drug targets susceptible Gram‑positive and Gram‑negative organisms.

Minocycline works by binding to the bacterial 30S ribosomal subunit, which blocks the attachment of aminoacyl‑tRNA to the growing peptide chain. This inhibition stops protein synthesis, producing a bacteriostatic effect that limits bacterial replication and helps the immune system clear the infection.

The dosage of Mino-50 is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local resistance patterns. Healthcare professionals set the exact amount and schedule; patients should follow the prescriber’s instructions precisely.

Safety data for minocycline in pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Mino-50, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Minocycline offers a longer half‑life and higher lipid solubility than doxycycline, allowing once‑ or twice‑daily dosing and better tissue penetration, especially in skin and respiratory tissues. However, it may have a higher incidence of vestibular side effects and photosensitivity, so clinicians weigh these factors against the therapeutic needs.

Mino-50 should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Mino-50 is taken orally with a full glass of water. It can be taken with or without food, but patients should avoid taking it simultaneously with antacids, iron, calcium or magnesium supplements, as these may reduce absorption. Swallow tablets whole; do not crush or chew them.

Serious adverse events include drug‑induced lupus erythematosus, Stevens‑Johnson syndrome or toxic epidermal necrolysis, severe hepatic injury, and anaphylactic reactions. Patients should seek immediate medical attention if they develop rash, fever, jaundice, or signs of severe hypersensitivity.

Mino-50 is contraindicated in individuals with a known hypersensitivity to minocycline, other tetracyclines, or any component of the formulation. It should also be avoided in patients with severe hepatic impairment, and used with caution in those with renal dysfunction, pregnancy, or lactation unless clearly indicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minocycline

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT